Closed
SectorHealthcare
108.28 1.21
24h
Min
105.31
Max
108.39
Income | -27M 103M |
---|---|
Sales | 5.6M 628M |
P/E Sector Avg | 33.617 63.778 |
EPS | 1.69 |
Profit margin | 16.425 |
Employees | 1,800 |
EBITDA | -39M 152M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +53.74% upside |
Next Earnings | 30 kwi 2025 |
---|
Market Cap | -3.8B 11B |
---|---|
Previous open | 107.07 |
Previous close | 108.28 |
By Acuity
50%
50%
180 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 164.5 USD 53.74%
High 192 USD
Low 138 USD
Based on 22 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$